Sanofi poised for $4B bond issue

Sanofi-Aventis is set to sell $4 billion in Euro-denominated bonds, divided into two tranches of $2 billion each: one with four-year maturities and the other with seven-year maturities. So far this year, drugmakers have been successful with bond investors on both sides of the Atlantic, with Roche completing record issues in both U.S. and Euro markets. Report

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.